The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The Diabetes Prevention Program (DPP) and its Outcomes Study (DPPOS) demonstrated that either intensive lifestyle intervention or metformin could prevent type 2 diabetes in high-risk adults for at least 10 years after randomization. We report the 10-year within-trial cost-effectiveness of the interventions. RESEARCH DESIGN AND METHODS: Data on resource utilization, cost, and quality of life were collected prospectively. Economic analyses were performed from health system and societal perspectives. RESULTS: Over 10 years, the cumulative, undiscounted per capita direct medical costs of the interventions, as implemented during the DPP, were greater for lifestyle ($4,572) than metformin ($2,281) or placebo ($752). The cumulative direct medical costs of care outside the DPP/DPPOS were least for lifestyle ($26,810 lifestyle vs. $27,384 metformin vs. $29,007 placebo). The cumulative, combined total direct medical costs were greatest for lifestyle and least for metformin ($31,382 lifestyle vs. $29,665 metformin vs. $29,759 placebo). The cumulative quality-adjusted life-years (QALYs) accrued over 10 years were greater for lifestyle (6.89) than metformin (6.79) or placebo (6.74). When costs and outcomes were discounted at 3% and adjusted for survival, lifestyle cost $12,878 per QALY, and metformin had slightly lower costs and nearly the same QALYs as placebo. CONCLUSIONS: Over 10 years, from a payer perspective, lifestyle was cost-effective and metformin was marginally cost-saving compared with placebo. Investment in lifestyle and metformin interventions for diabetes prevention in high-risk adults provides good value for the money spent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to potential for type 2 diabetes risk reduction, metformin therapy is also a feasible strategy in real world settings, given its association with cost savings. 15”
From Metformin Prescription Rates for Patients with Prediabetes (2022) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Both DPP-modeled intensive lifestyle interventions and individualized MNT for prediabetes have demonstrated costeffectiveness (17,36)”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Economic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Herman, W. H., Hoerger, T. J., Brandle, M., Hicks, K., Sorensen, S., Zhang, P., Hamman, R. F., Ackermann, R. T., Engelgau, M. M., Ratner, R. E., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00007 · Cited by 703
Does Preventive Care Save Money? Health Economics and the Presidential Candidates
Cohen, J. T., Neumann, P. J., & Weinstein, M. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmp0708558 · Cited by 471 · cited 1×
“Unfortunately, fewer than 1 in 5 new interventions in health and medicine are cost-saving compared with usual care (17).”
BackgroundThe Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.1.36 · Cited by 358
Self-citationRenjilian, D. A., Perri, M. G., Nezu, A. M., McKelvey, W. F., Shermer, R. L., & Anton, S. D. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.69.4.717 · Cited by 327 · cited 2×
“Studies have shown that group intervention programs can be as effective as individual programs (12,13).”
BackgroundClinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes
Eddy, D. M., Schlessinger, L., & Kahn, R. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-4-200508160-00006 · Cited by 318 · cited 2×
“However, one analysis suggested that lifestyle might be too expensive for health plans or a national program to implement (10).”
Background
Research works printed but not linked: 1
- Gold MR Siegel JE Russell LB Weinstein MC (Eds.). Cost-effectiveness in health and medicine. New York, Oxford University Press, 1996
Cited by
Items 101–200 of 499
Moin, T., Duru, O. K., Turk, N., Chon, J. S., Frosch, D. L., Martín, J. M., Jeffers, K. S., Castellon‐Lopez, Y., Tseng, C., Norris, K. C., et al. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05238-6 · Cited by 57
Value of Lifestyle Intervention to Prevent Diabetes and Sequelae
Dall, T. M., Storm, M. V., Semilla, A. P., Wintfeld, N., O’Grady, M., & Venkat Narayan, K. M. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.10.003 · Cited by 53
Metformin: an old therapy that deserves a new indication for the treatment of obesity.
Igel, L. I., Sinha, A., Saunders, K. H., Apovian, C. M., Vojta, D., & Aronne, L. J. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0568-3 · Cited by 52
Health Insurance Coverage Among People With and Without Diabetes in the U.S. Adult Population
Casagrande, S. S., & Cowie, C. C. (2012) · Diabetes Care · doi:10.2337/dc12-0257 · Cited by 52
Receipt of Glucose Testing and Performance of Two US Diabetes Screening Guidelines, 2007–2012
Bullard, K. M., Ali, M. K., Imperatore, G., Geiss, L. S., Saydah, S., Albu, J., Cowie, C. C., Sohler, N., Albright, A. L., & Gregg, E. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125249 · Cited by 51
Evidence for the Prevention of Type 2 Diabetes Mellitus
Shubrook, J. H., Chen, W., & Lim, A. (2018) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2018.158 · Cited by 54
Patel, Y. A., Gifford, E. J., Glass, L. M., McNeil, R. B., Turner, M. J., Han, B., Provenzale, D., Choi, S. S., Moylan, C. A., & Hunt, C. M. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14411 · Cited by 50
Coronary Heart Disease and Risk Factors in Latin America
Lanas, F. T., Pamela Serón, S., & Lanas, A. (2013) · Global Heart · doi:10.1016/j.gheart.2013.11.005 · Cited by 47
Assessing Systemic Disease Risk in a Dental Setting
Greenberg, B. L., & Glick, M. (2012) · Dental Clinics of North America · doi:10.1016/j.cden.2012.07.011 · Cited by 56
The 1-h post-load plasma glucose as a novel biomarker for diagnosing dysglycemia
Jagannathan, R., Buysschaert, M., Medina, J. L., Katz, K., Musleh, S., Dorcely, B., & Bergman, M. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1105-3 · Cited by 43
5. Prevention or Delay of Type 2 Diabetes
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc15-s008 · Cited by 61
Wu, E.-L., Kazzi, N. G., & Lee, J. M. (2013) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2013.419 · Cited by 45
Liu, X., Li, C., Gong, H., Cui, Z., Fan, L., Yu, W., Zhang, C., & Ma, J. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-729 · Cited by 42
The American Diabetes Association Diabetes Research Perspective
Fonseca, V. A., Kirkman, M. S., Darsow, T., & Ratner, R. E. (2012) · Diabetes Care · doi:10.2337/dc12-9001 · Cited by 48
Diabetes: An Update on the Pandemic and Potential Solutions
Ali, M. K., Siegel, K. R., Chandrasekar, E. K., Tandon, N., Montoya, P. A., Mbanya, J. C., Chan, J. C. N., Zhang, P., & Narayan, K. M. V. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0518-9_ch12 · Cited by 71
Unick, J. L., Pellegrini, C. A., Demos, K. E., & Dorfman, L. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0904-1 · Cited by 43
for the Diabetes Prevention Program Research Group, Hoskin, M. A., Bray, G. A., Hattaway, K., Khare-Ranade, P. A., Pomeroy, J., Semler, L. N., Weinzierl, V. A., & Wylie-Rosett, J. (2014) · Current Nutrition Reports · doi:10.1007/s13668-014-0094-2 · Cited by 40
Treating prediabetes: why and how should we do it?
Braga, T. G., Kraemer‐Aguiar, L. G., Docherty, N. G., & le Roux, C. W. (2019) · Minerva Medica · doi:10.23736/s0026-4806.18.05897-4 · Cited by 45
Impact of Mobile Diabetes Self-Care System on patients’ knowledge, behavior and efficacy
Guo, S. H.-M., Chang, H.-K., & Lin, C.-Y. (2014) · Computers in Industry · doi:10.1016/j.compind.2014.11.001 · Cited by 44
Wong, C. K. H., Jiao, F.-F., Siu, S.-C., Fung, C. S. C., Fong, D. Y. T., Wong, K.-W., Yu, E. Y. T., Lo, Y. Y. C., & Lam, C. L. K. (2016) · Journal of Diabetes Research · doi:10.1155/2016/1219581 · Cited by 39
Coste-efectividad de la intervención sobre el estilo de vida para prevenir la diabetes tipo 2
Sagarra-Alamo, R., Costa, B., Cabré, J. J., Solà-Morales, O., & Barrio, F. (2013) · Revista Clínica Española · doi:10.1016/j.rce.2013.10.005 · Cited by 43
Diabetes Prevention Program Community Outreach
Venditti, E. M., & Kramer, M. K. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.014 · Cited by 42
Cost-effectiveness of a primary care intervention to treat obesity
Tsai, A. G., Wadden, T. A., Volger, S., Sarwer, D. B., Vetter, M., Kumanyika, S., Berkowitz, R. I., Diewald, L. K., Perez, J., Lavenberg, J., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.94 · Cited by 37
Kullgren, J. T., Hafez, D., Fedewa, A., & Heisler, M. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0894-z · Cited by 43
Baral, J., Karki, K. B., Thapa, P., Timalsina, A., Bhandari, R., Bhandari, R., Kharel, B., & Adhikari, N. (2022) · Journal of Diabetes Research · doi:10.1155/2022/6136059 · Cited by 45
Pfammatter, A. F., Nahum-Shani, I. B., Dezelar, M., Scanlan, L., McFadden, H. G., Siddique, J., Hedeker, D., & Spring, B. J. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2019.05.007 · Cited by 36
Leal, J., Ahrabian, D., Davies, M. J., Gray, L. J., Khunti, K., Yates, T. E., & Gray, A. M. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013592 · Cited by 38
Kent, S., Aveyard, P., Astbury, N., Mihaylova, B., & Jebb, S. A. (2019) · Obesity · doi:10.1002/oby.22407 · Cited by 35
Cha, E., Kim, K. H., Umpierrez, G., Dawkins, C. R., Bello, M. K., Lerner, H. M., Narayan, K. M. V., & Dunbar, S. B. (2014) · The Diabetes Educator · doi:10.1177/0145721714539736 · Cited by 35
What's Preventing Us from Preventing Type 2 Diabetes?
Fradkin, J. E., Roberts, B. T., & Rodgers, G. P. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1208169 · Cited by 35
O’Brien, M. J., Lee, J. Y., Carnethon, M. R., Ackermann, R. T., Vargas, M. C., Hamilton, A., Mohanty, N., Rittner, S. S., Park, J. N., Hassan, A., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002074 · Cited by 36
Bourne, J. E., Ivanova, E. L., Gainforth, H. L., & Jung, M. E. (2019) · Translational Behavioral Medicine · doi:10.1093/tbm/ibz008 · Cited by 36
“Given the high financial cost of diabetes prevention programs [5], it is important for research efforts to establish the most effective method of improving the long-term impact of behavior change programs.”
BackgroundAlzubaidi, H., Chandir, S., Hasan, S., Namara, K. M., Cox, R., & Krass, I. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031246 · Cited by 35
Achila, O. O., Ghebretinsae, M., Kidane, A., Simon, M., Makonen, S., & Rezene, Y. (2020) · Journal of Diabetes Research · doi:10.1155/2020/5901569 · Cited by 34
Is Physical Exercise a Core Therapeutical Element for Most Patients With Type 2 Diabetes?
Feo, P. D., & Schwarz, P. E. H. (2013) · Diabetes Care · doi:10.2337/dcs13-2024 · Cited by 36
Hall, C., Stone, R. L., Gehlot, A., Zorn, K. K., & Burnett, A. (2015) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000603 · Cited by 35
Delivering Diabetes Education through Nurse-Led Telecoaching. Cost-Effectiveness Analysis
Odnoletkova, I., Ramaekers, D., Nobels, F., Goderis, G., Aertgeerts, B., & Annemans, L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163997 · Cited by 33
Alva, M. L., Chakkalakal, R. J., Moin, T., & Galaviz, K. I. (2022) · Health Affairs · doi:10.1377/hlthaff.2022.00259 · Cited by 33
Png, M. E., & Yoong, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107225 · Cited by 37
The Final Frontier in Diabetes Care: Implementing Research in Real-World Practice
Green, J. B., Crowley, M. J., Sathish, T., Maruthur, N. M., & Oldenburg, B. F. (2024) · Diabetes Care · doi:10.2337/dci24-0001 · Cited by 32
Utility of the U.S. Preventive Services Task Force Criteria for Diabetes Screening
Casagrande, S. S., Cowie, C. C., & FRADKIN, J. E. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.02.026 · Cited by 34
Siqueira-Catania, A., Cezaretto, A., de Barros, C. R., Salvador, E. P., dos Santos, T. C., & Ferreira, S. R. G. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-21 · Cited by 35
Glossmann, H. H., & Reider, N. (2013) · Dermato-Endocrinology · doi:10.4161/derm.23874 · Cited by 35
Epidemiology of Diabetes in Adults Aged 35 and Older from Shanghai, China.
Ruan, Y., Yan, Q. H., Xu, J. Y., Yang, Q. D., Yao, H. H., Li, R., & Shi, Y. (2016) · PubMed · doi:10.3967/bes2016.053 · Cited by 31
Hewage, S. S., Wu, S., Neelakantan, N., & Yoong, J. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.10.011 · Cited by 33
Weng, S., Luo, Y., Zhang, Z., Su, X., & Peng, D. (2020) · Endocrine · doi:10.1007/s12020-020-02190-y · Cited by 34
Greiner, G. G., Emmert-Fees, K. M. F., Becker, J., Rathmann, W., Thorand, B., Peters, A., Quante, A. S., Schwettmann, L., & Laxy, M. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01573-x · Cited by 34
Bharati, R., Kovach, K. A., Bonnet, J. P., Sayess, P., Polk, E., Harvey, K., & Vorbeck, L. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276211072506 · Cited by 31
Boltri, J. M., Tracer, H. L., Strogatz, D. S., Idzik, S. R., Schumacher, P., Fukagawa, N. K., Leake, E., Powell, C., Shell, D., Wu, S. S., et al. (2023) · Diabetes Care · doi:10.2337/dc22-0620 · Cited by 31
Cunningham, S. G., Stoddart, A., Wild, S. H., Conway, N. J., Gray, A. M., & Wake, D. J. (2022) · Journal of Diabetes Science and Technology · doi:10.26226/morressier.617c37317c09fc044a975247 · Cited by 32
Prediabetes in Colombia: Expert Consensus
López-Jaramillo, P. A., Calderón, C., Castillo, J., Escobar, I. D., Enrique Melgarejo, R., & Parra, G. A. (2017) · Colombia medica · doi:10.25100/cm.v48i4.3662 · Cited by 34
Rational Use of Electronic Health Records for Diabetes Population Management
Eggleston, E., & Klompas, M. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0479-z · Cited by 33
Shrestha, S. S., Zhang, P., Hora, I. A., & Gregg, E. W. (2019) · Diabetes Care · doi:10.2337/dc17-2683 · Cited by 27
Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care · doi:10.2337/dc25-0014 · Cited by 29
Gilmer, T., O’Connor, P. J., Schiff, J. S., Taylor, G., Vazquez‐Benitez, G., Garrett, J. E., Vue‐Her, H., Rinn, S., Anderson, J., & DESAI, J. R. (2018) · Health Services Research · doi:10.1111/1475-6773.12973 · Cited by 31
Chukir, T., Mandel, L., Tchang, B. G., Al-Mulla, N. A., Igel, L. I., Kumar, R. B., Waitman, J. A., Aronne, L. J., & Shukla, A. P. (2020) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2020.12.005 · Cited by 29
Smith, K. J., Kuo, S., Zgibor, J. C., McTigue, K. M., Hess, R., Bhargava, T. D., & Bryce, C. L. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.02.036 · Cited by 29
Vitamin D downregulates key genes of diabetes complications in cardiomyocyte
Derakhshanian, H., Djazayery, A., Javanbakht, M. H., Eshraghian, M. R., Mirshafiey, A., Jahanabadi, S., Ghadbeigi, S., Zarei, M., Alvandi, E., & Djalali, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28743 · Cited by 28
Role of metformin in the management of type 2 diabetes: recent advances
Gonzalez-Lopez, C., & Wojeck, B. S. (2023) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16511 · Cited by 28
Lifestyle interventions for diabetes mellitus type 2 prevention
Sagarra-Alamo, R., Costa, B., Cabré, J. J., Solà-Morales, O., & Barrio, F. (2013) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2013.11.003 · Cited by 30
Behavioural health consultants in integrated primary care teams: a model for future care
Dale, H., & Lee, A. (2016) · BMC Family Practice · doi:10.1186/s12875-016-0485-0 · Cited by 27
Rushing, J., Wing, R. R., Wadden, T. A., Knowler, W. C., Lawlor, M. S., Evans, M. E., Killean, T., Montez, M. G., Espeland, M. A., & Zhang, P. (2017) · Obesity Science & Practice · doi:10.1002/osp4.92 · Cited by 31
The global agenda for the prevention of type 2 diabetes
Herman, W. H. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw034 · Cited by 29
Shi, L., Ye, X., Lü, M., Wu, E. Q., Sharma, H., Thomason, D., & Fonseca, V. A. (2013) · Diabetes Care · doi:10.2337/dc13-0149 · Cited by 27
Hu, P. L., Koh, Y. L. E., & Tan, N. C. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.019 · Cited by 26
A Simple Model for Predicting Two-Year Risk of Diabetes Development in Individuals with Prediabetes
Glauber, H. S., Vollmer, W. M., & Nichols, G. A. (2018) · The Permanente Journal · doi:10.7812/tpp/17-050 · Cited by 28
Davy, B. M., Winett, R. A., Savla, J., Marinik, E. L., Baugh, M. E., Flack, K. D., Halliday, T. M., Kelleher, S. A., Winett, S. G., Williams, D. M., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0172610 · Cited by 25
Neighborhood walkability and pre-diabetes incidence in a multiethnic population
Fazli, G. S., Moineddin, R., Chu, A., Bierman, A. S., & Booth, G. L. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000908 · Cited by 25
Wang, X., Tian, B., Zhang, S., Zhang, J., Yang, W., Li, J., Wang, W., Wang, Y., & Zhang, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-45312-y · Cited by 29
Effects of a Health‐Partner Intervention on Cardiovascular Risk
Mheid, I. A., Kelli, H. M., Ko, Y., Hammadah, M., Ahmed, H. N., Hayek, S. S., Vaccarino, V., Ziegler, T. R., Gibson, G. C., Lampl, M., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004217 · Cited by 25
Tentolouris, N., Lathouris, P., Lontou, S. P., Tzemos, K., & Maynard, J. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.01.002 · Cited by 24
Preventing Type 2 Diabetes Mellitus: A Call for Personalized Intervention
Glauber, H. S., & Karnieli, E. (2013) · The Permanente Journal · doi:10.7812/tpp/12-143 · Cited by 26
The American Diabetes Association Diabetes Research Perspective
Fonseca, V. A., Kirkman, M. S., Darsow, T., & Ratner, R. E. (2012) · Diabetes · doi:10.2337/db12-0435 · Cited by 32
Subramanian, K., Midha, I., & Chellapilla, V. (2017) · Journal of Diabetes Research · doi:10.1155/2017/2615681 · Cited by 26
Rhee, S. Y., Sung, J. M., Kim, S., Cho, I., Lee, S., & Chang, H. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0081 · Cited by 24
“In addition to preventing the onset of T2DM, interventions may prevent the occurrence of long-term complications [5,6]; reports suggest that this approach is cost-effective [7].”
BackgroundBourne, J. E., Little, J. P., Beauchamp, M. R., Barry, J., Singer, J., & Jung, M. E. (2019) · JMIR Research Protocols · doi:10.2196/11226 · Cited by 24
Is there cardiac autonomic neuropathy in prediabetes?
Zilliox, L. A., & Russell, J. W. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102722 · Cited by 26
Ackermann, R. T., Kang, R., Cooper, A. J., Liss, D. T., Holmes, A. M., Moran, M., & Saha, C. (2019) · Diabetes Care · doi:10.2337/dc18-2071 · Cited by 22
Implementation of a Diabetes Prevention Program in Public Housing Communities
Whittemore, R., Rosenberg, A. P., Gilmore, L., Withey, M. B., & Breault, A. (2013) · Public Health Nursing · doi:10.1111/phn.12093 · Cited by 23
Sohler, N., Matti‐Orozco, B., Young, E., Li, X., Gregg, E. W., Ali, M. K., Bullard, K. M., & Albu, J. (2015) · Endocrine Practice · doi:10.4158/ep15866.or · Cited by 23
Cardiorespiratory Fitness and Health Care Costs in Diabetes: The Veterans Exercise Testing Study
MYERS, J. N., Silva, C. G. D. S. E., Doom, R., Fonda, H., Chan, K., Kamil‐Rosenberg, S., & Kokkinos, P. F. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.04.006 · Cited by 24
Zhang, P., Atkinson, K. M., Bray, G. A., Chen, H., Clark, J. M., Coday, M., Dutton, G. R., Egan, C., Espeland, M. A., Evans, M. E., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0358 · Cited by 23
Garst, J., L’Heveder, R., Siminerio, L. M., Motala, A. A., Gabbay, R. A., Chaney, D., & Cavan, D. A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.04.025 · Cited by 21
Real Incidence of Diabetes Mellitus in a Coronary Disease Population
de la Hera, J. M., García-Ruiz, J. M., Martínez‐Camblor, P., Martín, M. A. A., Tellería, A. L., Corros, C., Torres, F., Fernández-Cimadevilla, O. C., Pichel, I. A., Capín, E., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.10.008 · Cited by 20
Rhee, S. Y., Chon, S., Ahn, K. J., Woo, J., & The Korean Diabetes Prevention Study Investigators (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0033 · Cited by 21
Kuo, S., Ye, W., Wang, D., McEwen, L. N., Villatoro Santos, C., & Herman, W. H. (2025) · Diabetes Care · doi:10.2337/dc24-1110 · Cited by 19
Low metformin dose and its therapeutic serum concentration in prediabetes
Sutkowska, E., Fortuna, P., Wiśniewski, J. Ł., Sutkowska, K., Hodurek, P., Gamian, A., & Kałuża, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-91174-7 · Cited by 20
Role of Diabetes Self-management Education for Our Health Systems and Economy
Hatipoğlu, B., & Pronovost, P. J. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae913 · Cited by 21
Msane, S., Khathi, A., & Sosibo, A. M. (2024) · Nutrients · doi:10.3390/nu16162692 · Cited by 22
“The application of lifestyle intervention has also been reported as cost-effective for patients who adhere to it [88].”
BackgroundDiabetes Risk in a Cuban Primary Care Setting in Persons with No Known Glucose Abnormalities
Naranjo, A., Rodríguez, Á. Y., Llera, R. E., Aportela, R. A., Domínguez, A., Navarro, Á. Y. R., Almenteros, R. L., & Aportela, R. A. (2013) · MEDICC Review · doi:10.37757/mr2013v15.n2.4 · Cited by 25
Identifying prediabetes – Is it beneficial in the long run?
Ghody, P., Shikha, D., Karam, J., & Bahtiyar, G. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.03.022 · Cited by 18
Cost effectiveness and return on investment of a scalable community weight loss intervention
Michaud, T. L., You, W., Wilson, K. E., Su, D., McGuire, T. J., Almeida, F. A., Bayer, A. L., & Estabrooks, P. A. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.10.011 · Cited by 20
Armenta-Guirado, B. I., Martínez-Contreras, T. D. J., Candia-Plata, M. D. C., Esparza‐Romero, J., Martínez-Mir, R., Haby, M. M., Valencia, M. E., & Díaz-Zavala, R. G. (2019) · Nutrients · doi:10.3390/nu11102324 · Cited by 20
Productivity Benefits of Preventing Type 2 Diabetes in Australia: A 10-Year Analysis
Menon, K., de Courten, B. V., Liew, D., Ademi, Z., Owen, A. J., Magliano, D. J., & Zomer, E. (2021) · Diabetes Care · doi:10.2337/dc20-1429 · Cited by 18
DESAI, J. R., Taylor, G., Vazquez‐Benitez, G., Vine, S., Anderson, J., Garrett, J. E., Gilmer, T., Vue‐Her, H., Schiff, J., Rinn, S., et al. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.11.007 · Cited by 18
Pediatric Obesity: Influence on Drug Dosing and Therapeutics
Ameer, B., & Weintraub, M. A. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1092 · Cited by 19
Olson, B. P., Matter, N. I., Ediger, M. N., Hull, E. L., & Maynard, J. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700422 · Cited by 17
Liu, L., Guan, X., Yuan, Z., Zhao, M., Li, Q., Zhang, X., Zhang, H., Zheng, D., Xu, J., Gao, L., et al. (2019) · Journal of Diabetes Research · doi:10.1155/2019/4328975 · Cited by 17
Self-citationCost-effectiveness of a Stepwise Approach vs Standard Care for Diabetes Prevention in India
İşlek, D., Weber, M. B., Mohan, A. R., Mohan, V., Staimez, L. R., Ranjani, H., Narayan, K. M. V., Laxy, M., & Ali, M. K. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.7539 · Cited by 17
Gabosines P and Q, new carbasugars from Streptomyces sp. and their α-glucosidase inhibitory activity
Wei, J., Liu, L.-L., Dong, S., Li, H., Tang, D., Zhang, Q., Xue, Q., & Gao, J. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.09.021 · Cited by 16
Metadata
- Authors
- The Diabetes Prevention Program Research Group
- Affiliations
- University of Michigan (US)
- Corresponding author
- The Diabetes Prevention Program Research Group
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-03-13
- Volume
- 35
- Issue
- 4
- Pages
- 723-730
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3308273
- OpenAlex
- W1896651021
- Cited by
- 436
- References
- 22
- Citations by year
- 2026: 16 · 2025: 19 · 2024: 22 · 2023: 19 · 2022: 19 · 2021: 28 · 2020: 38 · 2019: 42 · 2018: 39 · 2017: 43 · 2016: 38 · 2015: 32 · 2014: 29 · 2013: 31 · 2012: 19
- FWCI
- 84.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK092926, P30DK017047)
- National Center for Research Resources
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes prevention, lifestyle intervention, metformin, cost-effectiveness, Diabetes Prevention Program Outcomes Study, quality-adjusted life years, high-risk adults, direct medical costs, resource utilization (health care), health system perspective, societal perspective
- MeSH terms
- Adult, Combined Modality Therapy, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Prediabetic State, Prognosis, Time Factors, Randomized Controlled Trials as Topic, Treatment Outcome, Risk Reduction Behavior, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.